Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-Month results from a randomized controlled study-Response.
作者信息
Li Songshan, Ding Xiaoyan, Zhang Junyan, Lu Lin
机构信息
State Key Laboratory of Ophthalmology, Retina Division, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Scientific supporting department, Bothwin Clinical Study Consultant, Shanghai, China.
出版信息
Clin Exp Ophthalmol. 2019 Jul;47(5):685-686. doi: 10.1111/ceo.13507. Epub 2019 Apr 15.
PMID:30938055
Abstract
摘要
Zotero 插件